Meiji Pharma
Since the beginning of this century, Meiji and Tramedico have been partners. Meiji has over 25 years of expertise in hyaluronic acid-based products for joint and eye treatments, highlighting their reliability and experience.
Meiji Pharma
Since 1991, Meiji Pharma has been a leading player in the pharmaceutical industry, known for its innovative and high-quality products. In the Netherlands, Tramedico markets Adant, an intra-articular treatment based on hyaluronic acid. Adant is prescribed to treat pain and reduced mobility caused by osteoarthritis, helping patients improve their quality of life.
Adant has been approved in more than 45 countries worldwide and has been used in over 13 million treatments for patients globally.